Compared to individual drug treatment, the combination of IFN-γ and PFD significantly inhibited TGF-β1-induced ACTA2 and α-SMA expression in NHLFs and IPF fibroblasts (p < 0.01, Fig. 4a-d). The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.